A photo of Amy Shah.

Director, Adolescent Type 2 Diabetes Program

Associate Professor, UC Department of Pediatrics

513-636-4744

513-636-7486

Board Certified

Best Doctors logo

My Biography & Research

Biography

Dr. Shah is a board-certified pediatric endocrinologist and clinical lipidologist. She is also director of the Adolescent Type 2 Diabetes Program at Cincinnati Children's Hospital Medical Center. Her research focuses on best medial treatments for youth with type 2 diabetes, the effects of bariatric surgery in youth- onset type 2 diabetes, and the effects of youth onset type 2 diabetes on cardiovascular risk. Dr. Shah has active clinical and basic science research programs. Dr. Shah has received several prestigious awards including Young Investigator Awards from The International Society of Pediatric and Adolescent Diabetes Young Investigator Award, The National Lipid Association, The American Society of Clinical Investigation and The Central Society for Clinical and Translational Research. She enjoys teaching and mentoring students, residents and endocrine fellows.

Clinical Interests

Type 2 diabetes; obesity; primary and secondary lipid disorders; hypertension; general endocrinology

Research Interests

Type 2 diabetes; type 1 diabetes; cardiovascular risk factors; lipids and lipoproteins

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Divisions

Endocrinology, Endocrinology

My Locations

My Education

BA: Biology, The University of Texas at Austin, Austin, TX, 2000. 

MD: St. George’s University Medical School, Grenada, West Indies, 2004.

Pediatric Residency: Loyola University Medical Center, Maywood, IL, 2007.

Endocrine Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2010.

Research Fellowship: Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2011.

MS: Clinical Research, The University of Cincinnati, Cincinnati, OH, 2011.

Certifications: The American Board of Pediatrics, Subspeciality Board in Pediatric Endocrinology, Clinical Lipidology.

My Publications

Obesity and type 2 diabetes are associated with elevated PCSK9 levels in young women (vol 18, pg 756, 2017). Levenson, AE; Shah, AS; Khoury, PR; Kimball, TR; Urbina, EM; de Ferranti, SD; Maahs, DM; Dolan, LM; Wadwa, RP; Biddinger, SB. Pediatric Diabetes. 2020; 21:143-143.

Metabolic outcomes of surgery in youth with type 2 diabetes. Shah, AS; Nadeau, KJ; Helmrath, MA; Inge, TH; Xanthakos, SA; Kelsey, MM. Seminars in Pediatric Surgery. 2020; 29:150893-150893.

Adolescent Metabolic/Bariatric Surgery: Effects on Obesity, Comorbidities, and Insulin Resistance. Hsia, DS; Shah, AS; Inge, T. Contemporary Endocrinology. : Springer International Publishing; Springer International Publishing; 2020.

Effect of surgical versus medical therapy on diabetic kidney disease over 5 years in severely obese adolescents with type 2 diabetes. Bjornstad, P; Hughan, K; Kelsey, MM; Shah, AS; Lynch, J; Nehus, E; Mitsnefes, M; Jenkins, T; Xu, P; Xie, C; et al. Diabetes Care. 2020; 43:187-195.

A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR. Safarova, MS; Satterfield, BA; Fan, X; Austin, EE; Ye, Z; Bastarache, L; Zheng, N; Ritchie, MD; Borthwick, KM; Williams, MS; et al. npj Genomic Medicine. 2019; 4.

A phenome-wide association study to discover pleiotropic effects of PCSK9, APOB, and LDLR. Safarova, MS; Satterfield, BA; Fan, X; Austin, EE; Ye, Z; Bastarache, L; Zheng, N; Ritchie, MD; Borthwick, KM; Williams, MS; et al. npj Genomic Medicine. 2019; 4.

Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population. Semova, I; Levenson, AE; Krawczyk, J; Bullock, K; Williams, KA; Wadwa, RP; Shah, AS; Khoury, PR; Kimball, TR; Urbina, EM; et al. Journal of Clinical Lipidology. 2019; 13:940-946.

Heart rate variability and cardiac autonomic dysfunction: Prevalence, risk factors, and relationship to arterial stiffness in the treatment options for type 2 diabetes in adolescents and youth (TODAY) study. Shah, AS; El Ghormli, L; Vajravelu, ME; Bacha, F; Farrell, RM; Gidding, SS; Katz, LE L; Tryggestad, JB; White, NH; Urbina, EM. Diabetes Care. 2019; 42:2143-2150.

A large-scale study reveals 24-h operational rhythms in hospital treatment. Ruben, MD; Francey, LJ; Guo, Y; Wu, G; Cooper, EB; Shah, AS; Hogenesch, JB; Smith, DF. Proceedings of the National Academy of Sciences of USA. 2019; 116:20953-20958.

Burden of Cardiovascular Risk Factors Over Time and Arterial Stiffness in Youth With Type 1 Diabetes Mellitus: The SEARCH for Diabetes in Youth Study. Urbina, EM; Bell, RA; Bowlby, DA; Jr, DR; Daniels, SR; Marcovina, SM; Merchant, AT; Shah, AS; Wadwa, RP; Lawrence, JM; et al. Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease. 2019; 8.